152 related articles for article (PubMed ID: 22981725)
1. The binding of resveratrol to monomer and fibril amyloid beta.
Ge JF; Qiao JP; Qi CC; Wang CW; Zhou JN
Neurochem Int; 2012 Dec; 61(7):1192-201. PubMed ID: 22981725
[TBL] [Abstract][Full Text] [Related]
2. The anti-amyloidogenic effect is exerted against Alzheimer's beta-amyloid fibrils in vitro by preferential and reversible binding of flavonoids to the amyloid fibril structure.
Hirohata M; Hasegawa K; Tsutsumi-Yasuhara S; Ohhashi Y; Ookoshi T; Ono K; Yamada M; Naiki H
Biochemistry; 2007 Feb; 46(7):1888-99. PubMed ID: 17253770
[TBL] [Abstract][Full Text] [Related]
3. Specific binding of a β-cyclodextrin dimer to the amyloid β peptide modulates the peptide aggregation process.
Wahlström A; Cukalevski R; Danielsson J; Jarvet J; Onagi H; Rebek J; Linse S; Gräslund A
Biochemistry; 2012 May; 51(21):4280-9. PubMed ID: 22554145
[TBL] [Abstract][Full Text] [Related]
4. Molecular dynamics simulations of Aβ fibril interactions with β-sheet breaker peptides.
Bruce NJ; Chen D; Dastidar SG; Marks GE; Schein CH; Bryce RA
Peptides; 2010 Nov; 31(11):2100-8. PubMed ID: 20691234
[TBL] [Abstract][Full Text] [Related]
5. Single chain variable fragments against beta-amyloid (Abeta) can inhibit Abeta aggregation and prevent abeta-induced neurotoxicity.
Liu R; Yuan B; Emadi S; Zameer A; Schulz P; McAllister C; Lyubchenko Y; Goud G; Sierks MR
Biochemistry; 2004 Jun; 43(22):6959-67. PubMed ID: 15170333
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of cytotoxicity and amyloid fibril formation by a D-amino acid peptide that specifically binds to Alzheimer's disease amyloid peptide.
Wiesehan K; Stöhr J; Nagel-Steger L; van Groen T; Riesner D; Willbold D
Protein Eng Des Sel; 2008 Apr; 21(4):241-6. PubMed ID: 18252750
[TBL] [Abstract][Full Text] [Related]
7. Protective effect of ε-viniferin on β-amyloid peptide aggregation investigated by electrospray ionization mass spectrometry.
Richard T; Poupard P; Nassra M; Papastamoulis Y; Iglésias ML; Krisa S; Waffo-Teguo P; Mérillon JM; Monti JP
Bioorg Med Chem; 2011 May; 19(10):3152-5. PubMed ID: 21524590
[TBL] [Abstract][Full Text] [Related]
8. Lipocalin-type prostaglandin D synthase/beta-trace is a major amyloid beta-chaperone in human cerebrospinal fluid.
Kanekiyo T; Ban T; Aritake K; Huang ZL; Qu WM; Okazaki I; Mohri I; Murayama S; Ozono K; Taniike M; Goto Y; Urade Y
Proc Natl Acad Sci U S A; 2007 Apr; 104(15):6412-7. PubMed ID: 17404210
[TBL] [Abstract][Full Text] [Related]
9. Resveratrol inhibits beta-amyloid oligomeric cytotoxicity but does not prevent oligomer formation.
Feng Y; Wang XP; Yang SG; Wang YJ; Zhang X; Du XT; Sun XX; Zhao M; Huang L; Liu RT
Neurotoxicology; 2009 Nov; 30(6):986-95. PubMed ID: 19744518
[TBL] [Abstract][Full Text] [Related]
10. Structural, morphological, and kinetic studies of β-amyloid peptide aggregation on self-assembled monolayers.
Wang Q; Shah N; Zhao J; Wang C; Zhao C; Liu L; Li L; Zhou F; Zheng J
Phys Chem Chem Phys; 2011 Sep; 13(33):15200-10. PubMed ID: 21769359
[TBL] [Abstract][Full Text] [Related]
11. Alzheimer's disease amyloid β-protein mutations and deletions that define neuronal binding/internalization as early stage nonfibrillar/fibrillar aggregates and late stage fibrils.
Poduslo JF; Howell KG; Olson NC; Ramirez-Alvarado M; Kandimalla KK
Biochemistry; 2012 May; 51(19):3993-4003. PubMed ID: 22545812
[TBL] [Abstract][Full Text] [Related]
12. Surface plasmon resonance imaging of amyloid-β aggregation kinetics in the presence of epigallocatechin gallate and metals.
Cheng XR; Hau BY; Veloso AJ; Martic S; Kraatz HB; Kerman K
Anal Chem; 2013 Feb; 85(4):2049-55. PubMed ID: 23276205
[TBL] [Abstract][Full Text] [Related]
13. Laminin inhibition of beta-amyloid protein (Abeta) fibrillogenesis and identification of an Abeta binding site localized to the globular domain repeats on the laminin a chain.
Castillo GM; Lukito W; Peskind E; Raskind M; Kirschner DA; Yee AG; Snow AD
J Neurosci Res; 2000 Nov; 62(3):451-62. PubMed ID: 11054814
[TBL] [Abstract][Full Text] [Related]
14. A multimeric quinacrine conjugate as a potential inhibitor of Alzheimer's beta-amyloid fibril formation.
Dolphin GT; Chierici S; Ouberai M; Dumy P; Garcia J
Chembiochem; 2008 Apr; 9(6):952-63. PubMed ID: 18330854
[TBL] [Abstract][Full Text] [Related]
15. Development of a proteolytically stable retro-inverso peptide inhibitor of beta-amyloid oligomerization as a potential novel treatment for Alzheimer's disease.
Taylor M; Moore S; Mayes J; Parkin E; Beeg M; Canovi M; Gobbi M; Mann DM; Allsop D
Biochemistry; 2010 Apr; 49(15):3261-72. PubMed ID: 20230062
[TBL] [Abstract][Full Text] [Related]
16. Curcuminoid binds to amyloid-β1-42 oligomer and fibril.
Yanagisawa D; Taguchi H; Yamamoto A; Shirai N; Hirao K; Tooyama I
J Alzheimers Dis; 2011; 24 Suppl 2():33-42. PubMed ID: 21335654
[TBL] [Abstract][Full Text] [Related]
17. Small heat shock proteins inhibit amyloid-beta protein aggregation and cerebrovascular amyloid-beta protein toxicity.
Wilhelmus MM; Boelens WC; Otte-Höller I; Kamps B; de Waal RM; Verbeek MM
Brain Res; 2006 May; 1089(1):67-78. PubMed ID: 16635482
[TBL] [Abstract][Full Text] [Related]
18. Ex situ atomic force microscopy analysis of beta-amyloid self-assembly and deposition on a synthetic template.
Ha C; Park CB
Langmuir; 2006 Aug; 22(16):6977-85. PubMed ID: 16863248
[TBL] [Abstract][Full Text] [Related]
19. NMR reveals two-step association of Congo Red to amyloid β in low-molecular-weight aggregates.
Pedersen MØ; Mikkelsen K; Behrens MA; Pedersen JS; Enghild JJ; Skrydstrup T; Malmendal A; Nielsen NC
J Phys Chem B; 2010 Dec; 114(48):16003-10. PubMed ID: 21077638
[TBL] [Abstract][Full Text] [Related]
20. Tabersonine inhibits amyloid fibril formation and cytotoxicity of Aβ(1-42).
Kai T; Zhang L; Wang X; Jing A; Zhao B; Yu X; Zheng J; Zhou F
ACS Chem Neurosci; 2015 Jun; 6(6):879-88. PubMed ID: 25874995
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
